Skip to content

CHMP backs talquetamab combinations for relapsed or refractory multiple myeloma
Five-year remission rates with cilta-cel in earlier-line relapsed or refractory multiple myeloma
Drs. Phillip Scheinberg, Imre Bodó and Ciprian Tomuleasa on the inaugural SOHO CE meeting
The history of SOHO as told by Hagop Kantarjian, MD
What have we learned about treating lower-risk MDS?

Insider Reader Survey

Join SOHO

Insider Podcast
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
Meeting News
Multimedia
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

MDS News

Leukemia Acute Lymphoblastic Leukemia Lymphoma Aggressive B-Cell Lymphomas Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News

Drs. Krish Patel and Gwen Nichols join SOHO Insider community oncology series

by SOHO Insider Editors
March 16, 2026
0 Comments

Leukemia Acute Lymphoblastic Leukemia SOHO UK Multiple Myeloma Myelodysplastic Syndromes News Video Interviews

Dr. Jessica Manson discusses multidisciplinary HLH management at SOHO UK

by SOHO Insider Editors
March 11, 2026
0 Comments

Cellular Therapy Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Multiple Myeloma Myelodysplastic Syndromes News

Why clinicians should lead hospitals, according to Prof. Amanda Goodall

by Leah Sherwood
March 10, 2026
0 Comments

Ambassador Program SOHO Asia 2026 Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News

Yu-Hung Wang, MD, PhD, discusses unmet needs in myeloid neoplasms at SOHO Asia

by SOHO Insider Editors
February 10, 2026
0 Comments

Leukemia Acute Myeloid Leukemia ASH 2025 Myelodysplastic Syndromes Video Interviews

Dr. Kelly Bolton on ivosidenib in IDH1-mutated CCUS

by Leah Sherwood
January 21, 2026
0 Comments

ASH 2025 Myelodysplastic Syndromes

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

by SOHO Insider Editors
January 15, 2026
0 Comments

Leukemia Chronic Myeloid Leukemia Myelodysplastic Syndromes News

Pathways & Perspectives with Valeria Santini, MD

by Leah Sherwood
November 25, 2025
0 Comments

Myelodysplastic Syndromes News

FDA grants orphan drug designation to MDS investigational therapy ofirnoflast

by SOHO Insider Editors
October 23, 2025
0 Comments

Acute Lymphoblastic Leukemia Aggressive B-Cell Lymphomas ESMO 2025 Multiple Myeloma Myelodysplastic Syndromes

Despite digital advances, cancer research remains costly, burdensome

by Leah Sherwood
October 22, 2025
0 Comments

ESMO 2025 Myelodysplastic Syndromes News

Bexmarilimab continues to show strong efficacy in phase 1/2 trial update

by Leah Sherwood
October 21, 2025
0 Comments

1
2
3
4
5
6

Top Categories

Cellular Therapy

82

Leukemia

141

Lymphoma

143

Multiple Myeloma

123

Myelodysplastic Syndromes

51

Myeloproliferative Neoplasms

40

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

MDS News

Drs. Krish Patel and Gwen Nichols join SOHO Insider community oncology series

Dr. Jessica Manson discusses multidisciplinary HLH management at SOHO UK

Why clinicians should lead hospitals, according to Prof. Amanda Goodall

Yu-Hung Wang, MD, PhD, discusses unmet needs in myeloid neoplasms at SOHO Asia

Dr. Kelly Bolton on ivosidenib in IDH1-mutated CCUS

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Pathways & Perspectives with Valeria Santini, MD

FDA grants orphan drug designation to MDS investigational therapy ofirnoflast

Despite digital advances, cancer research remains costly, burdensome

Bexmarilimab continues to show strong efficacy in phase 1/2 trial update

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Society Updates

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

CHMP backs talquetamab combinations for relapsed or refractory multiple myeloma

Five-year remission rates with cilta-cel in earlier-line relapsed or refractory multiple myeloma

Drs. Phillip Scheinberg, Imre Bodó and Ciprian Tomuleasa on the inaugural SOHO CE meeting

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

MDS News

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Society Updates

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms